Edwards Lifesciences Corporation EW

86.29 0.56 0.65% as of 25 Sep
Market cap
$49.4B
P/E
49.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Edwards Lifesciences Corporation (EW) P/E ratio

As of 25 September 2026, Edwards Lifesciences Corporation (EW) trades at a P/E ratio of 49.6×. Over the past ten years it has ranged from 9.3× (October 2024) to 77.0× (June 2021); the current reading is higher than 79% of that period. That is above the Medical Devices industry median of 22.2× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 46.3× 336.84%
FY2024 10.6× (67.58%)
FY2023 32.7× 7.92%
FY2022 30.3× (43.37%)
FY2021 53.5× (22.74%)
FY2020 69.3× 49.11%
FY2019 46.5× 4.36%
FY2018 44.5× 10.46%
FY2017 40.3× 12.68%
FY2016 35.8× 3.94%

Quarterly

Period P/E ratio Change
Jun 2026 52.0× 22.70%
Mar 2026 42.4× (8.55%)
Dec 2025 46.3× 38.81%
Sep 2025 33.4× 197.46%
42 more quarters

Against its own ten years

Low 9.3× High 77.0×
Ten-year median 39.7×
Current reading's percentile 79

P/E ratio against peers

Company P/E ratio
GEHC GE HealthCare Technologies Inc. compare 15.3×
BSX Boston Scientific Corporation compare 17.7×
PHG Koninklijke Philips N.V. compare 18.2×
MDT Medtronic PLC compare 21.7×
ZBH Zimmer Biomet Holdings, Inc. compare 22.0×
STE STERIS plc compare 25.4×
SYK Stryker Corporation compare 28.0×
DXCM DexCom, Inc. compare 33.4×
EW Edwards Lifesciences Corporation 49.6×
Medical Devices industry median 22.2×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on EW